Story · Medicine & Biotech
GLP-1 drugs linked to lower kidney failure risk in bipolar disorder: Study
1 outlet · first reported by Medical Dialogues 4d ago
Coverage, in order
-
4d ago
GLP-1 drugs linked to lower kidney failure risk in bipolar disorder: StudyMayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease. The study, published in the Journal of Clinical…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.